These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 15667487

  • 1. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
    Talwalkar JA, Angulo P, Keach JC, Petz JL, Jorgensen RA, Lindor KD.
    Am J Gastroenterol; 2005 Feb; 100(2):308-12. PubMed ID: 15667487
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
    Talwalkar JA, Angulo P, Keach JC, Petz JL, Jorgensen RA, Lindor KD.
    J Clin Gastroenterol; 2005 Feb; 39(2):168-71. PubMed ID: 15681915
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
    Eaton JE, Nelson KM, Gossard AA, Carey EJ, Tabibian JH, Lindor KD, LaRusso NF.
    Scand J Gastroenterol; 2019 May; 54(5):633-639. PubMed ID: 31131678
    [Abstract] [Full Text] [Related]

  • 4. Oral budesonide in the treatment of primary sclerosing cholangitis.
    Angulo P, Batts KP, Jorgensen RA, LaRusso NA, Lindor KD.
    Am J Gastroenterol; 2000 Sep; 95(9):2333-7. PubMed ID: 11007238
    [Abstract] [Full Text] [Related]

  • 5. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
    Sterling RK, Salvatori JJ, Luketic VA, Sanyal AJ, Fulcher AS, Stravitz RT, Contos MJ, Mills AS, Shiffman ML.
    Aliment Pharmacol Ther; 2004 Nov 01; 20(9):943-9. PubMed ID: 15521841
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T, Peters M, Schlaak JF, Krummenauer F, Wanitschke R, Mayet WJ, Galle PR, Neurath MF.
    Am J Gastroenterol; 2000 May 01; 95(5):1201-7. PubMed ID: 10811328
    [Abstract] [Full Text] [Related]

  • 7. Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study.
    Silveira MG, Torok NJ, Gossard AA, Keach JC, Jorgensen RA, Petz JL, Lindor KD.
    Am J Gastroenterol; 2009 Jan 01; 104(1):83-8. PubMed ID: 19098854
    [Abstract] [Full Text] [Related]

  • 8. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jan 01; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 9. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
    Harnois DM, Angulo P, Jorgensen RA, Larusso NF, Lindor KD.
    Am J Gastroenterol; 2001 May 01; 96(5):1558-62. PubMed ID: 11374699
    [Abstract] [Full Text] [Related]

  • 10. A pilot study of etanercept in the treatment of primary sclerosing cholangitis.
    Epstein MP, Kaplan MM.
    Dig Dis Sci; 2004 Jan 01; 49(1):1-4. PubMed ID: 14992426
    [Abstract] [Full Text] [Related]

  • 11. A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.
    Zhu GQ, Shi KQ, Huang GQ, Wang LR, Lin YQ, Braddock M, Chen YP, Zhou MT, Zheng MH.
    Oncotarget; 2015 Sep 29; 6(29):26757-69. PubMed ID: 26378046
    [Abstract] [Full Text] [Related]

  • 12. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
    Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug 29; 249(8):1235-43. PubMed ID: 21720813
    [Abstract] [Full Text] [Related]

  • 13. Treatment of atopic eczema with oral mycophenolate mofetil.
    Neuber K, Schwartz I, Itschert G, Dieck AT.
    Br J Dermatol; 2000 Aug 29; 143(2):385-91. PubMed ID: 10951150
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis.
    Bharucha AE, Jorgensen R, Lichtman SN, LaRusso NF, Lindor KD.
    Am J Gastroenterol; 2000 Sep 29; 95(9):2338-42. PubMed ID: 11007239
    [Abstract] [Full Text] [Related]

  • 15. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma.
    Stratton RJ, Wilson H, Black CM.
    Rheumatology (Oxford); 2001 Jan 29; 40(1):84-8. PubMed ID: 11157146
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.
    Swigris JJ, Olson AL, Fischer A, Lynch DA, Cosgrove GP, Frankel SK, Meehan RT, Brown KK.
    Chest; 2006 Jul 29; 130(1):30-6. PubMed ID: 16840379
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb 29; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
    Lankarani KB.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1279-80; author reply 1280. PubMed ID: 15882250
    [No Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.
    Aw MM, Dhawan A, Samyn M, Bargiota A, Mieli-Vergani G.
    J Hepatol; 2009 Jul 15; 51(1):156-60. PubMed ID: 19446911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.